Allostery in GPCRs: 'MWC' revisited - PubMed (original) (raw)
Review
. 2011 Dec;36(12):663-72.
doi: 10.1016/j.tibs.2011.08.005. Epub 2011 Sep 14.
Affiliations
- PMID: 21920759
- DOI: 10.1016/j.tibs.2011.08.005
Review
Allostery in GPCRs: 'MWC' revisited
Meritxell Canals et al. Trends Biochem Sci. 2011 Dec.
Abstract
G protein-coupled receptors (GPCRs) constitute the largest family of receptors in the genome and are the targets for at least 30% of current medicines. In recent years, there has been a dramatic increase in the discovery of allosteric modulators of GPCR activity and a growing appreciation of the diverse modes by which GPCRs can be regulated by both orthosteric and allosteric ligands. Interestingly, some of the contemporary views of GPCR function reflect characteristics that are shared by prototypical allosteric proteins, as encompassed in the classic Monod-Wyman-Changeux (MWC) model initially proposed for enzymes and subsequently extended to other protein families. In this review, we revisit the MWC model in the context of emerging structural, functional and operational data on GPCR allostery.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
- [Operational models of allosteric modulation of G protein-coupled receptors].
Gong H, Zhang S, Ye RD. Gong H, et al. Yao Xue Xue Bao. 2016 Dec;51(12):1829-37. Yao Xue Xue Bao. 2016. PMID: 29908534 Review. Chinese. - Allosteric modulation of G-protein coupled receptors.
Jensen AA, Spalding TA. Jensen AA, et al. Eur J Pharm Sci. 2004 Mar;21(4):407-20. doi: 10.1016/j.ejps.2003.11.007. Eur J Pharm Sci. 2004. PMID: 14998571 Review. - Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
Burford NT, Watson J, Bertekap R, Alt A. Burford NT, et al. Biochem Pharmacol. 2011 Mar 15;81(6):691-702. doi: 10.1016/j.bcp.2010.12.012. Epub 2010 Dec 22. Biochem Pharmacol. 2011. PMID: 21184747 Review. - Allosteric modulation of G protein-coupled receptors: a pharmacological perspective.
Keov P, Sexton PM, Christopoulos A. Keov P, et al. Neuropharmacology. 2011 Jan;60(1):24-35. doi: 10.1016/j.neuropharm.2010.07.010. Epub 2010 Jul 15. Neuropharmacology. 2011. PMID: 20637785 Review. - Orthosteric/allosteric bitopic ligands: going hybrid at GPCRs.
Valant C, Sexton PM, Christopoulos A. Valant C, et al. Mol Interv. 2009 Jun;9(3):125-35. doi: 10.1124/mi.9.3.6. Mol Interv. 2009. PMID: 19592673 Review.
Cited by
- Development of M1 mAChR allosteric and bitopic ligands: prospective therapeutics for the treatment of cognitive deficits.
Davie BJ, Christopoulos A, Scammells PJ. Davie BJ, et al. ACS Chem Neurosci. 2013 Jul 17;4(7):1026-48. doi: 10.1021/cn400086m. Epub 2013 May 23. ACS Chem Neurosci. 2013. PMID: 23659787 Free PMC article. Review. - Assessment of the Molecular Mechanisms of Action of Novel 4-Phenylpyridine-2-One and 6-Phenylpyrimidin-4-One Allosteric Modulators at the M1 Muscarinic Acetylcholine Receptors.
van der Westhuizen ET, Spathis A, Khajehali E, Jörg M, Mistry SN, Capuano B, Tobin AB, Sexton PM, Scammells PJ, Valant C, Christopoulos A. van der Westhuizen ET, et al. Mol Pharmacol. 2018 Jul;94(1):770-783. doi: 10.1124/mol.118.111633. Epub 2018 Apr 24. Mol Pharmacol. 2018. PMID: 29691279 Free PMC article. - Regulation of G protein-coupled receptors by allosteric ligands.
Lane JR, Abdul-Ridha A, Canals M. Lane JR, et al. ACS Chem Neurosci. 2013 Apr 17;4(4):527-34. doi: 10.1021/cn400005t. Epub 2013 Feb 21. ACS Chem Neurosci. 2013. PMID: 23398684 Free PMC article. Review. - An Allosteric Potentiator of the Dopamine D1 Receptor Increases Locomotor Activity in Human D1 Knock-In Mice without Causing Stereotypy or Tachyphylaxis.
Svensson KA, Heinz BA, Schaus JM, Beck JP, Hao J, Krushinski JH, Reinhard MR, Cohen MP, Hellman SL, Getman BG, Wang X, Menezes MM, Maren DL, Falcone JF, Anderson WH, Wright RA, Morin SM, Knopp KL, Adams BL, Rogovoy B, Okun I, Suter TM, Statnick MA, Gehlert DR, Nelson DL, Lucaites VL, Emkey R, DeLapp NW, Wiernicki TR, Cramer JW, Yang CR, Bruns RF. Svensson KA, et al. J Pharmacol Exp Ther. 2017 Jan;360(1):117-128. doi: 10.1124/jpet.116.236372. Epub 2016 Nov 3. J Pharmacol Exp Ther. 2017. PMID: 27811173 Free PMC article. - Na+-mimicking ligands stabilize the inactive state of leukotriene B4 receptor BLT1.
Hori T, Okuno T, Hirata K, Yamashita K, Kawano Y, Yamamoto M, Hato M, Nakamura M, Shimizu T, Yokomizo T, Miyano M, Yokoyama S. Hori T, et al. Nat Chem Biol. 2018 Mar;14(3):262-269. doi: 10.1038/nchembio.2547. Epub 2018 Jan 8. Nat Chem Biol. 2018. PMID: 29309055
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources